Soumya Eswaran
3 min read
Cambiar Opportunity Fund, managed by Cambiar Investors, published its Q2 2026 investor letter. The letter can be downloaded here. U.S. equity markets experienced a significant rebound in Q2, with the S&P 500 rising 15.2% and the Russell 2000 up 21.5%. Growth stocks outperformed value, although value retained a year-to-date lead. The market’s rise was fueled by technology and AI stocks, which now dominate the S&P 500, accounting for nearly 50%. Notably, the demand for advanced AI chips has become a structural opportunity in the semiconductor sector, surpassing previous cycles. Despite strong profit margins, caution is warranted due to extreme valuation metrics. The Cambiar Opportunity Fund gained 11.58% (CAMOX) but lagged behind the Russell 1000 Value Index’s 13.87% gain, reflecting an underweight in tech. The market remains speculative, illustrated by the recent SpaceX IPO and the rapid rise in memory chip stock prices. Overall, while market leadership was driven by a few tech stocks, future uncertainties including geopolitical conflicts and AI disruption may challenge economic growth and specific company earnings. Portfolio construction focuses on broad ownership across diverse sectors. Additionally, reviewing the Fund’s top five holdings could help identify its best picks for 2026.
In its second-quarter 2026 investor letter, Cambiar Opportunity Fund highlighted CME Group Inc. (NASDAQ:CME). CME Group Inc. (NASDAQ:CME) is a leading financial derivative marketplace operator specializing in futures and options products. On September 30, 2026, CME Group Inc. (NASDAQ:CME) closed at $261.98 per share. Over the past month, CME Group Inc. (NASDAQ:CME) declined 5.39%, and its shares gained 0.53% over the past 52 weeks. CME Group Inc. (NASDAQ:CME) has a market capitalization of $94.2 billion with a 52-week trading range between $218.31 and $329.16.
Cambiar Opportunity Fund stated the following regarding CME Group Inc. (NASDAQ:CME) in its Q2 2026 investor letter:
“Additional performance headwinds in the quarter included an overweight allocation to Consumer Staples and below-benchmark returns in Financials. Within Financials, the primary laggard was the aforementioned CME Group Inc. (NASDAQ:CME), which declined despite posting all-time highs in both trading volumes and revenue. We added to our position in the quarter.”
CME Group Inc. (NASDAQ:CME) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 88 hedge fund portfolios held CME Group Inc. (NASDAQ:CME) at the end of the second quarter which was 70 in the previous quarter. While we acknowledge the potential of CME Group Inc. (NASDAQ:CME) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
